CN115806976A - 利用环形rna进行蛋白翻译及其应用 - Google Patents

利用环形rna进行蛋白翻译及其应用 Download PDF

Info

Publication number
CN115806976A
CN115806976A CN202211124976.0A CN202211124976A CN115806976A CN 115806976 A CN115806976 A CN 115806976A CN 202211124976 A CN202211124976 A CN 202211124976A CN 115806976 A CN115806976 A CN 115806976A
Authority
CN
China
Prior art keywords
translation initiation
container
sequence
construct
seq
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN202211124976.0A
Other languages
English (en)
Chinese (zh)
Inventor
王泽峰
杨赟
樊晓娟
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Shanghai Huanma Biopharmaceutical Co ltd
Original Assignee
Shanghai Institute of Nutrition and Health
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Shanghai Institute of Nutrition and Health filed Critical Shanghai Institute of Nutrition and Health
Priority to CN202211124976.0A priority Critical patent/CN115806976A/zh
Publication of CN115806976A publication Critical patent/CN115806976A/zh
Pending legal-status Critical Current

Links

Images

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/67—General methods for enhancing the expression
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C12N15/111—General methods applicable to biologically active non-coding nucleic acids
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2840/00—Vectors comprising a special translation-regulating system
    • C12N2840/20—Vectors comprising a special translation-regulating system translation of more than one cistron
    • C12N2840/203—Vectors comprising a special translation-regulating system translation of more than one cistron having an IRES
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P21/00—Preparation of peptides or proteins
    • C12P21/02—Preparation of peptides or proteins having a known sequence of two or more amino acids, e.g. glutathione

Landscapes

  • Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Biomedical Technology (AREA)
  • Chemical & Material Sciences (AREA)
  • Wood Science & Technology (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Zoology (AREA)
  • Molecular Biology (AREA)
  • Microbiology (AREA)
  • Biophysics (AREA)
  • Physics & Mathematics (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Plant Pathology (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
CN202211124976.0A 2019-03-20 2019-03-20 利用环形rna进行蛋白翻译及其应用 Pending CN115806976A (zh)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN202211124976.0A CN115806976A (zh) 2019-03-20 2019-03-20 利用环形rna进行蛋白翻译及其应用

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
CN201910214234.9A CN111718929B (zh) 2019-03-20 2019-03-20 利用环形rna进行蛋白翻译及其应用
CN202211124976.0A CN115806976A (zh) 2019-03-20 2019-03-20 利用环形rna进行蛋白翻译及其应用

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
CN201910214234.9A Division CN111718929B (zh) 2019-03-20 2019-03-20 利用环形rna进行蛋白翻译及其应用

Publications (1)

Publication Number Publication Date
CN115806976A true CN115806976A (zh) 2023-03-17

Family

ID=72519626

Family Applications (6)

Application Number Title Priority Date Filing Date
CN202211124976.0A Pending CN115806976A (zh) 2019-03-20 2019-03-20 利用环形rna进行蛋白翻译及其应用
CN201910214234.9A Active CN111718929B (zh) 2019-03-20 2019-03-20 利用环形rna进行蛋白翻译及其应用
CN202410975296.2A Pending CN118834867A (zh) 2019-03-20 2020-02-27 利用环形rna进行蛋白翻译及其应用
CN202410093532.8A Pending CN117965533A (zh) 2019-03-20 2020-02-27 利用环形rna进行蛋白翻译及其应用
CN202080036818.2A Pending CN113825837A (zh) 2019-03-20 2020-02-27 利用环形rna进行蛋白翻译及其应用
CN202410975341.4A Pending CN118834868A (zh) 2019-03-20 2020-02-27 利用环形rna进行蛋白翻译及其应用

Family Applications After (5)

Application Number Title Priority Date Filing Date
CN201910214234.9A Active CN111718929B (zh) 2019-03-20 2019-03-20 利用环形rna进行蛋白翻译及其应用
CN202410975296.2A Pending CN118834867A (zh) 2019-03-20 2020-02-27 利用环形rna进行蛋白翻译及其应用
CN202410093532.8A Pending CN117965533A (zh) 2019-03-20 2020-02-27 利用环形rna进行蛋白翻译及其应用
CN202080036818.2A Pending CN113825837A (zh) 2019-03-20 2020-02-27 利用环形rna进行蛋白翻译及其应用
CN202410975341.4A Pending CN118834868A (zh) 2019-03-20 2020-02-27 利用环形rna进行蛋白翻译及其应用

Country Status (5)

Country Link
US (1) US20220177898A1 (cg-RX-API-DMAC7.html)
EP (1) EP3943601A4 (cg-RX-API-DMAC7.html)
JP (4) JP7297331B2 (cg-RX-API-DMAC7.html)
CN (6) CN115806976A (cg-RX-API-DMAC7.html)
WO (1) WO2020186991A1 (cg-RX-API-DMAC7.html)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN112608946B (zh) * 2021-01-17 2023-07-28 楷拓生物科技(苏州)有限公司 一种环状rna载体及其在疫苗中的应用
AR127073A1 (es) 2021-09-17 2023-12-13 Flagship Pioneering Innovations Vi Llc Composiciones y métodos para producir polirribonucleótidos circulares
EP4771042A1 (en) 2023-08-29 2026-07-08 Shanghai Circode Biomed Co., Ltd Circular rna encoding vegf polypeptides, formulations, and methods of uses
CN122029278A (zh) * 2023-10-09 2026-05-12 上海环码生物医药有限公司 制备环状rna的构建体、方法及其用途

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN108690139A (zh) * 2017-07-31 2018-10-23 康码(上海)生物科技有限公司 新型融合蛋白的制备及其在提高蛋白质合成的应用
CN109022478A (zh) * 2017-06-09 2018-12-18 康码(上海)生物科技有限公司 一种用于高通量体外蛋白质合成的dna元件
CN109423497A (zh) * 2017-08-31 2019-03-05 康码(上海)生物科技有限公司 增强蛋白质合成效率的rna元件
CN109423496A (zh) * 2017-08-31 2019-03-05 康码(上海)生物科技有限公司 一种细胞中内源性表达rna聚合酶的核酸构建物

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7863430B2 (en) * 2000-03-28 2011-01-04 Queensland University Of Technology Construct capable of release in closed circular form from a larger nucleotide sequence permitting site specific expression and/or developmentally regulated expression of selected genetic sequences
AU2001250572A1 (en) * 2000-04-07 2001-10-23 Epigenomics Ag Detection of single nucleotide polymorphisms (snp's) and cytosine-methylations
JP2006518214A (ja) * 2003-02-13 2006-08-10 株式会社インテレクチャル・プロパティ・コンサルティング 神経障害および疾患の診断および処置のための遺伝子マーカー、組成物およびその利用
US20110129873A1 (en) * 2008-04-30 2011-06-02 Monsanto Technology Llc Recombinant DNA Vectors for Expression of Human Prolactin Antagonists
WO2012177639A2 (en) * 2011-06-22 2012-12-27 Alnylam Pharmaceuticals, Inc. Bioprocessing and bioproduction using avian cell lines
CN105985978B (zh) * 2015-03-06 2020-02-14 中国科学院上海生命科学研究院 一种新型rna环化表达载体的构建及其应用
US20170298347A1 (en) * 2016-02-03 2017-10-19 Beth Israel Deaconess Medical Center NOVEL FUSION-CIRCULAR RNAs AND USES THEREOF
MX2020006150A (es) * 2017-12-15 2020-11-11 Flagship Pioneering Innovations Vi Llc Composiciones que comprenden polirribonucleotidos circulares y usos de las mismas.
CN109971775B (zh) * 2017-12-27 2021-12-28 康码(上海)生物科技有限公司 一种核酸构建物及其调控蛋白合成的方法

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN109022478A (zh) * 2017-06-09 2018-12-18 康码(上海)生物科技有限公司 一种用于高通量体外蛋白质合成的dna元件
CN108690139A (zh) * 2017-07-31 2018-10-23 康码(上海)生物科技有限公司 新型融合蛋白的制备及其在提高蛋白质合成的应用
CN109423497A (zh) * 2017-08-31 2019-03-05 康码(上海)生物科技有限公司 增强蛋白质合成效率的rna元件
CN109423496A (zh) * 2017-08-31 2019-03-05 康码(上海)生物科技有限公司 一种细胞中内源性表达rna聚合酶的核酸构建物

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
XIAOJUAN FAN等: "Pervasive translation of circular RNAs driven by short IRES-like elements", 《BIORXIV》, 18 November 2018 (2018-11-18), pages 5 - 6 *
YANG YUN等: "Extensive translation of circular RNAs driven by N-6-methyladenosine", 《CELL RESEARCH》, vol. 27, no. 5, 31 May 2017 (2017-05-31), pages 627 *

Also Published As

Publication number Publication date
CN117965533A (zh) 2024-05-03
EP3943601A1 (en) 2022-01-26
JP7297331B2 (ja) 2023-06-26
JP7673989B2 (ja) 2025-05-09
US20220177898A1 (en) 2022-06-09
JP2025029079A (ja) 2025-03-05
CN118834868A (zh) 2024-10-25
CN118834867A (zh) 2024-10-25
EP3943601A4 (en) 2022-12-14
CN113825837A (zh) 2021-12-21
CN111718929B (zh) 2022-10-18
WO2020186991A1 (zh) 2020-09-24
JP2023116620A (ja) 2023-08-22
JP2025029080A (ja) 2025-03-05
CN111718929A (zh) 2020-09-29
JP2022528252A (ja) 2022-06-09

Similar Documents

Publication Publication Date Title
Gao et al. A truncated reverse transcriptase enhances prime editing by split AAV vectors
Cao et al. High-throughput 5′ UTR engineering for enhanced protein production in non-viral gene therapies
JP7673989B2 (ja) 環状rnaを使用したタンパク質翻訳およびその応用
Mirzadeh et al. Enhanced protein production in Escherichia coli by optimization of cloning scars at the vector–coding sequence junction
CN103429743B (zh) 构建特异性启动子的方法
JP7436488B2 (ja) Aavベクター及びプロモーターの単一細胞トランスクリプトームベースの開発のための方法及び材料
Deaner et al. Modular ligation extension of guide RNA operons (LEGO) for multiplexed dCas9 regulation of metabolic pathways in Saccharomyces cerevisiae
US12098373B2 (en) Bacillus subtilis efficiently-induced expression system based on artificial series promoter
Meyer et al. Library generation by gene shuffling
Guerin et al. A novel next-generation sequencing and analysis platform to assess the identity of recombinant adeno-associated viral preparations from viral DNA extracts
Duan et al. Deciphering the rules of ribosome binding site differentiation in context dependence
Sasso et al. A long non-coding SINEUP RNA boosts semi-stable production of fully human monoclonal antibodies in HEK293E cells
WO2008023247A2 (en) Matrix attachment regions (mars) for increasing transcription and uses thereof
Liu et al. Leaderless bicistronic design for precise and reliable control of gene expression in Corynebacterium glutamicum
Tzimou et al. Unlocking DOE potential by selecting the most appropriate design for rAAV optimization
Ravi et al. A deep learning model trained on expressed transcripts across different tissue types reveals cell-type codon-optimization preferences
Stadelmann et al. A deep mutational scanning platform to characterize the fitness landscape of anti-CRISPR proteins
Sørensen et al. The branched receptor-binding complex of Ackermannviridae phages promotes adaptive host recognition
Jansen et al. Interrogating the function of bicistronic translational control elements to improve consistency of gene expression
Herynek et al. Increasing recombinant protein production in E. coli via FACS‐based selection of N‐terminal coding DNA libraries
Wadley et al. Nanopore sequencing for detection and characterization of phosphorothioate modifications in native DNA sequences
HK40057766A (en) Protein translation using circular rna and application thereof
Burkhart et al. Unveiling Small Non‐Coding RNA Dynamics During Recombinant Adeno‐Associated Virus Production
Fai Alex Wong et al. Engineering artificial 5′ regulatory sequences for thermostable protein expression in the extremophile Thermus thermophilus
Mauro Condon Optimization: Codon Optimization of Therapeutic Proteins: Suggested Criteria for Increased Efficacy and Safety

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination
TA01 Transfer of patent application right

Effective date of registration: 20231116

Address after: 200131, Room 901, 9th Floor, No. 8 Jiafeng Road, China (Shanghai) Pilot Free Trade Zone, Pudong New Area, Shanghai

Applicant after: Shanghai Huanma Biopharmaceutical Co.,Ltd.

Address before: No.319, Yueyang Road, Xuhui District, Shanghai 200031

Applicant before: Shanghai Institute of nutrition and health, Chinese Academy of Sciences

TA01 Transfer of patent application right